Leiden Clinical Prediction Rule for Undifferentiated Arthritis
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۰ — حداکثر ۶۸ • واحد: joints
حداقل ۰ — حداکثر ۶۶ • واحد: joints
حداقل ۰ — حداکثر ۵۰۰ • واحد: mg/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–6
- Indeterminate Risk6.01–7.99
- High Risk8–20
The Leiden Clinical Prediction Rule for Undifferentiated Arthritis calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include age years. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis by predicting the likelihood of progression from undifferentiated arthritis to rheumatoid arthritis within one year
Clinical Indication
The Leiden Clinical Prediction Rule for Undifferentiated Arthritis is indicated for bedside clinical practice to support Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis by predicting the likelihood of progression from undifferentiated arthritis to rheumatoid arthritis within one year. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.
Limitations & Contraindications
Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.
Clinical Pearls & Action Plan
Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: High specificity for identifying patients who will progress to RA.
Score = (Age × 0.02) + Sex points + Joint distribution points + Symmetric distribution points + Morning stiffness points + Tender joints points + Swollen joints points + CRP points + RF points + Anti-CCP points
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_years | integer | Yes | Patient age in years (multiplied by 0.02 in calculation)(years) |
| sex | string | Yes | Patient sex |
| joint_distribution | string | Yes | Distribution pattern of affected joints |
| symmetric_distribution | string | Yes | Whether joint involvement is symmetric |
| morning_stiffness_duration | string | Yes | Duration of morning stiffness |
| tender_joints_count | integer | Yes | Number of tender joints (out of 68 assessed joints)(joints) |
| swollen_joints_count | integer | Yes | Number of swollen joints (out of 66 assessed joints)(joints) |
| c_reactive_protein | float | Yes | C-reactive protein level(mg/L) |
| rheumatoid_factor | string | Yes | Presence of rheumatoid factor |
| anti_ccp_antibodies | string | Yes | Presence of anti-cyclic citrullinated peptide (anti-CCP) antibodies |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–6 | Low Risk | Low risk of progression to rheumatoid arthritis |
| 6.01–7.99 | Indeterminate Risk | Indeterminate risk of progression to rheumatoid arthritis |
| 8–20 | High Risk | High risk of progression to rheumatoid arthritis |
Evidence-Based References (EBM)
- van der Helm-van Mil AHM, le Cessie S, van Dongen H, Breedveld FC, Toes REM, Huizinga TWJ. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007 Feb;56(2):433-40.
- Kuriya B, Cheng CK, Chen HM, Bykerk VP. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis. Ann Rheum Dis. 2009 Sep;68(9):1482-5.
- Tamai M, Kawakami A, Uetani M, Fukushima A, Arima K, Iwanaga N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009 Oct 15;61(10):1324-31.